Indegene Inc: metaMe Health partners with Indegene to launch Regulora, an FDA-cleared Prescription Digital Therapeutic for adults with Irritable Bowel Syndrome

PRINCETON, N.J. and CHICAGO, March 22, 2022 (GLOBE NEWSWIRE) -- Indegene, a technology-led global healthcare solutions provider, and metaMe Health, Inc. (metaMe), a Prescription Digital Therapeutics (PDT)

Related Keywords

United States ,Chicago ,Illinois ,Delilah Bennett ,Healthon Linkedin ,Kostenloser Wertpapierhandel ,Olafur Palsson ,Nathan Piland ,Shefali Kotnala ,Tim Rudolphi ,Me Health Regulora ,Points Communications ,Division Of Gastroenterology ,Sme Health ,University Of North Carolina ,Digital Therapeutics Alliance ,Me Health Inc ,Gastrointestinal Society ,Prescription Digital Therapeutics ,Irritable Bowel Syndrome ,Prescription Digital ,Vice President ,Digital Therapeutics ,Mehealthon Twitter ,Impact Report ,Digital Therapeutics Definition ,Core Principles Fact ,Accessed January ,Indegene ,Detame ,Health ,Partners ,Launch ,Egulora ,Leared ,Prescription ,Digital ,Herapeutic ,Adults ,Irritable ,Towel ,Yndrome ,